Latest news
{{'2026-10-29T12:05:31Z' | dateFormatFilter}}
Novo to present new CagriSema and Wegovy® data at ObesityWeek® 2026, including data on treatment experience with Wegovy® pill in the real world
{{'2026-10-28T13:00:00Z' | dateFormatFilter}}
Novo to present new liver data across Wegovy 2.4 mg and investigational efruxifermin at The Liver Meeting® (AASLD) 2026
{{'2026-10-20T13:00:00Z' | dateFormatFilter}}
Novo’s CagriSema was associated with 25% weight loss on average for women in a post hoc analysis of REDEFINE 1 presented at The Menopause Society Annual Meeting
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
